These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 12957697)

  • 1. Endothelial dysfunction in young patients with long-term rheumatoid arthritis and low disease activity.
    Hänsel S; Lässig G; Pistrosch F; Passauer J
    Atherosclerosis; 2003 Sep; 170(1):177-80. PubMed ID: 12957697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of anti-tumor necrosis factor (TNF)-alpha therapy with etanercept on endothelial functions in patients with rheumatoid arthritis.
    Tikiz H; Arslan O; Pirildar T; Tikiz C; Bayindir P
    Anadolu Kardiyol Derg; 2010 Apr; 10(2):98-103. PubMed ID: 20382605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor necrosis factor antagonism with etanercept improves systemic endothelial vasoreactivity in patients with advanced heart failure.
    Fichtlscherer S; Rössig L; Breuer S; Vasa M; Dimmeler S; Zeiher AM
    Circulation; 2001 Dec; 104(25):3023-5. PubMed ID: 11748093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial dysfunction in patients with rheumatoid arthritis is associated with a reduced number and impaired function of endothelial progenitor cells.
    Herbrig K; Haensel S; Oelschlaegel U; Pistrosch F; Foerster S; Passauer J
    Ann Rheum Dis; 2006 Feb; 65(2):157-63. PubMed ID: 15975971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Open-label observation of addition of etanercept versus a conventional disease-modifying antirheumatic drug in subjects with active rheumatoid arthritis despite methotrexate therapy in the Latin American region.
    Machado DA; Guzman RM; Xavier RM; Simon JA; Mele L; Pedersen R; Ferdousi T; Koenig AS; Kotak S; Vlahos B
    J Clin Rheumatol; 2014 Jan; 20(1):25-33. PubMed ID: 24356474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical improvement in rheumatoid arthritis is associated with healthier microvascular function in patients who respond to antirheumatic therapy.
    Galarraga B; Belch JJ; Pullar T; Ogston S; Khan F
    J Rheumatol; 2010 Mar; 37(3):521-8. PubMed ID: 20080919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The safety and efficacy of adding etanercept to methotrexate or methotrexate to etanercept in moderately active rheumatoid arthritis patients previously treated with monotherapy.
    van der Heijde D; Burmester G; Melo-Gomes J; Codreanu C; Mola EM; Pedersen R; Freundlich B; Chang DJ;
    Ann Rheum Dis; 2008 Feb; 67(2):182-8. PubMed ID: 17728331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-tumour necrosis factor-alpha therapy over conventional therapy improves endothelial function in adults with rheumatoid arthritis.
    Bilsborough W; Keen H; Taylor A; O'Driscoll GJ; Arnolda L; Green DJ
    Rheumatol Int; 2006 Oct; 26(12):1125-31. PubMed ID: 16799778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum levels of lipoprotein(a) and E-selectin are reduced in rheumatoid arthritis patients treated with methotrexate or methotrexate in combination with TNF-α-inhibitor.
    Hjeltnes G; Hollan I; Førre O; Wiik A; Lyberg T; Mikkelsen K; Agewall S
    Clin Exp Rheumatol; 2013; 31(3):415-21. PubMed ID: 23465067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative study of etanercept plus methotrexate and methotrexate alone in Taiwanese patients with active rheumatoid arthritis: a 12-week, double-blind, randomized, placebo-controlled study.
    Lan JL; Chou SJ; Chen DY; Chen YH; Hsieh TY; Young M
    J Formos Med Assoc; 2004 Aug; 103(8):618-23. PubMed ID: 15340661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term efficacy of etanercept plus methotrexate vs combinations of disease-modifying anti-rheumatic drugs with methotrexate in established rheumatoid arthritis.
    Fleischmann R; Koenig AS; Szumski A; Nab HW; Marshall L; Bananis E
    Rheumatology (Oxford); 2014 Nov; 53(11):1984-93. PubMed ID: 24907147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of inflammation and cardiovascular disease risk on microvascular and macrovascular endothelial function in patients with rheumatoid arthritis: a cross-sectional and longitudinal study.
    Sandoo A; Kitas GD; Carroll D; Veldhuijzen van Zanten JJ
    Arthritis Res Ther; 2012 May; 14(3):R117. PubMed ID: 22594788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Etanercept (ETN) with methotrexate (MTX) is better than ETN monotherapy in patients with active rheumatoid arthritis despite MTX therapy: a randomized trial.
    Kameda H; Ueki Y; Saito K; Nagaoka S; Hidaka T; Atsumi T; Tsukano M; Kasama T; Shiozawa S; Tanaka Y; Takeuchi T;
    Mod Rheumatol; 2010 Dec; 20(6):531-8. PubMed ID: 20574649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of DAS28-ESR remission at 6 months by baseline variables in patients with rheumatoid arthritis treated with etanercept in Japanese population.
    Iwamoto N; Kawakami A; Fujikawa K; Aramaki T; Kawashiri SY; Tamai M; Arima K; Ichinose K; Kamachi M; Yamasaki S; Nakamura H; Nakashima M; Mizokami A; Goto A; Fukuda T; Matsuoka N; Ueki Y; Tsukada T; Migita K; Shoumura F; Kawabe Y; Shibatomi K; Mine M; Ida H; Origuchi T; Aoyagi K; Eguchi K
    Mod Rheumatol; 2009; 19(5):488-92. PubMed ID: 19578932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etanercept in combination with conventional disease-modifying antirheumatic drugs (DMARDs) in the treatment of rheumatoid arthritis patients intolerant to methotrexate.
    Koyama Y; Shiraishi H; Ohta T; Uchino A
    Mod Rheumatol; 2012 Feb; 22(1):100-8. PubMed ID: 21706263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of etanercept treatment in elderly subjects with rheumatoid arthritis.
    Bathon JM; Fleischmann RM; Van der Heijde D; Tesser JR; Peloso PM; Chon Y; White B
    J Rheumatol; 2006 Feb; 33(2):234-43. PubMed ID: 16465653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasodilator function worsens after cessation of tumour necrosis factor inhibitor therapy in patients with rheumatoid arthritis only if a flare occurs.
    Rongen GA; van Ingen I; Kok M; Vonkeman H; Janssen M; Jansen TL
    Clin Rheumatol; 2018 Apr; 37(4):909-916. PubMed ID: 29307093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis.
    Hürlimann D; Forster A; Noll G; Enseleit F; Chenevard R; Distler O; Béchir M; Spieker LE; Neidhart M; Michel BA; Gay RE; Lüscher TF; Gay S; Ruschitzka F
    Circulation; 2002 Oct; 106(17):2184-7. PubMed ID: 12390945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methotrexate modulates the kinetics of adenosine in humans in vivo.
    Riksen NP; Barrera P; van den Broek PH; van Riel PL; Smits P; Rongen GA
    Ann Rheum Dis; 2006 Apr; 65(4):465-70. PubMed ID: 16308339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient-reported health outcomes in a trial of etanercept monotherapy versus combination therapy with etanercept and methotrexate for rheumatoid arthritis: the ADORE trial.
    van Riel PL; Freundlich B; MacPeek D; Pedersen R; Foehl JR; Singh A;
    Ann Rheum Dis; 2008 Aug; 67(8):1104-10. PubMed ID: 17666447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.